A detailed history of Institutional & Family Asset Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Institutional & Family Asset Management, LLC holds 2,020 shares of ABBV stock, worth $369,518. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,020
Previous 1,608 25.62%
Holding current value
$369,518
Previous $292,000 18.49%
% of portfolio
0.04%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 05, 2024

BUY
$154.79 - $180.76 $63,773 - $74,473
412 Added 25.62%
2,020 $346,000
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $13,424 - $15,296
-84 Reduced 4.96%
1,608 $292,000
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $2,614 - $2,944
19 Added 1.14%
1,692 $262,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $2,805 - $3,247
21 Added 1.27%
1,673 $249,000
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $530 - $659
-4 Reduced 0.24%
1,652 $222,000
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $28,488 - $32,808
197 Added 13.5%
1,656 $263,000
Q4 2022

Feb 08, 2023

SELL
$138.31 - $165.87 $12,309 - $14,762
-89 Reduced 5.75%
1,459 $235,000
Q3 2022

Nov 07, 2022

SELL
$134.21 - $153.93 $19,863 - $22,781
-148 Reduced 8.73%
1,548 $208,000
Q2 2022

Aug 08, 2022

SELL
$137.62 - $174.96 $28,349 - $36,041
-206 Reduced 10.83%
1,696 $260,000
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $1,583 - $1,965
12 Added 0.63%
1,902 $308,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $4,082 - $5,165
-38 Reduced 1.97%
1,890 $256,000
Q3 2021

Nov 10, 2021

BUY
$106.4 - $120.78 $13,300 - $15,097
125 Added 6.93%
1,928 $208,000
Q2 2021

Aug 10, 2021

SELL
$105.21 - $117.21 $54,183 - $60,363
-515 Reduced 22.22%
1,803 $203,000
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $7,161 - $7,883
70 Added 3.11%
2,318 $251,000
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $6,117 - $8,258
-76 Reduced 3.27%
2,248 $241,000
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $225,943 - $265,182
-2,630 Reduced 53.09%
2,324 $204,000
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $95,747 - $128,124
1,305 Added 35.76%
4,954 $486,000
Q1 2020

May 14, 2020

BUY
$64.5 - $97.79 $35,152 - $53,295
545 Added 17.56%
3,649 $278,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $39,094 - $48,915
-542 Reduced 14.87%
3,104 $275,000
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $57,248 - $68,829
909 Added 33.21%
3,646 $276,000
Q2 2019

Aug 14, 2019

SELL
$65.7 - $83.98 $1,051 - $1,343
-16 Reduced 0.58%
2,737 $199,000
Q1 2019

May 13, 2019

BUY
$77.14 - $90.79 $231 - $272
3 Added 0.11%
2,753 $222,000
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $90,383 - $111,467
-1,161 Reduced 29.69%
2,750 $253,000
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $156,659 - $174,156
-1,762 Reduced 31.06%
3,911 $370,000
Q2 2018

Aug 13, 2018

BUY
$89.78 - $106.23 $118,509 - $140,223
1,320 Added 30.32%
5,673 $526,000
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $13,801 - $18,481
150 Added 3.57%
4,353 $412,000
Q4 2017

Feb 14, 2018

SELL
$89.56 - $98.21 $2,328 - $2,553
-26 Reduced 0.61%
4,203 $406,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $16,764 - $21,412
240 Added 6.02%
4,229 $376,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,989
3,989 $289,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Institutional & Family Asset Management, LLC Portfolio

Follow Institutional & Family Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Institutional & Family Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Institutional & Family Asset Management, LLC with notifications on news.